PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference69 articles.
1. PIK3CA in cancer: the past 30 years;Arafeh;Semin. Cancer Biol.,2019
2. Genetic deregulation of the PIK3CA oncogene in oral cancer;Murugan;Cancer Lett.,2013
3. PTEN: an intercellular peacekeeper?;Leslie;Sci. Signal.,2012
4. AKT in cancer: new molecular insights and advances in drug development;Mundi;Br. J. Clin. Pharmacol.,2016
5. Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer;Miller;J. Clin. Oncol.,2011
Cited by 736 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. LARP1, an RNA-binding protein, participates in ovarian cancer cell survival by regulating mitochondrial oxidative phosphorylation in response to the influence of the PI3K/mTOR pathway;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12
2. Protective effect of folic acid on MNNG-induced proliferation of esophageal epithelial cells via the PI3K/AKT/mTOR signaling pathway;The Journal of Nutritional Biochemistry;2024-11
3. Design, synthesis, and in vivo and in vitro biological screening of pseudolaric acid B derivatives as potential anti-tumor agents;Bioorganic Chemistry;2024-10
4. CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer;Cell Death & Disease;2024-09-10
5. Oxyresveratrol Enhances the Anti-Cancer Effect of Cisplatin against Epithelial Ovarian Cancer Cells through Suppressing the Activation of Protein Kinase B (AKT);Biomolecules;2024-09-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3